Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Cancer Investigation|August 29, 2002
Premedication strategy for weekly paclitaxelJustin Quock, Gilland Dea, Michael Tanaka, et al.American Journal of Clinical Oncology|June 6, 2008
Population-based phase I trial of irinotecan and epirubicinDerick Lau, Jewel Johl, Minh Huynh, et al.International Journal of Cardiology. Heart & Vasculature|June 19, 2020
Coronavirus disease 2019 and cardiovascular system: A narrative reviewFelix Kwenandar, Karunia Valeriani Japar, Vika Damay, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancerHenry Wang, Janice Ryu, David Gandara, et al.Oncology (Williston Park, N.Y.)|July 31, 2003
Population-based maximum tolerated dose of irinotecan and carboplatinCarolyn A Wild, Stephen E Wang, David R Gandara, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 20, 2007
Phase I study of two different schedules of bortezomib and pemetrexed in advanced solid tumors with emphasis on non-small cell lung cancerAngela M Davies, Cheryl Ho, Alex S Metzger, et al.Cancer Investigation|March 20, 2003
Phase I trial of gemcitabine and paclitaxel in advanced solid tumorsNelson Lim, Primo N Lara, Derick H M Lau, et al.Investigational New Drugs|February 12, 2010
Escalating weekly doses of cetuximab and correlation with skin toxicity: a phase I studyCheryl Ho, Randeep Sangha, Laurel Beckett, et al.International Journal of Clinical Oncology|August 6, 2014
Pharmacodynamic separation of gemcitabine and erlotinib in locally advanced or metastatic pancreatic cancer: therapeutic and biomarker resultsThomas Semrad, Afsaneh Barzi, Heinz-Josef Lenz, et al.Cancer Chemotherapy and Pharmacology|January 27, 2009
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancerRamesh K Ramanathan, Chandra P Belani, Deepti A Singh, et al.Pageof 2